George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,653.00
Bid: 1,654.00
Ask: 1,654.50
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,638.50
High: 1,655.50
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: FCA, bank competition, Glaxo

Sun, 30th Mar 2014 16:53

Big insurance companies want Martin Wheatley, Chief Executive of the Financial Conduct Authority, to resign after the watchdog sent their shares into freefall by making a misleading announcement about an industry probe, the Sunday Times said. The Association of British Insurers is expected to write to Chancellor George Osborne to complain about the FCA. Senior sources at four of Britain's biggest insurers told the paper Wheatley's position was untenable.Andrew Tyrie, Chairman of the Treasury Select Committee, has accused the Financial Conduct Authority of an "extraordinary blunder" in announcing market sensitive information about the insurance sector, the Sunday Telegraph reported. Insurer shares fell heavily on Friday after FCA Director of Supervision Clive Adamson told the Telegraph the watchdog planned an inquiry into pensions dating back to the 1970s. Tyrie said the FCA's pledge to bring in an external law firm to investigate the affair was not enough and that his committee would probably vet the inquiry head.The head of the Competition and Markets Authority (CMA) has said Labour leader Ed Miliband's plan for a swift breakup of Britain's banks is unworkable, the Sunday Telegraph reported. Alex Chisholm, Chief Executive of the new competition regulator, said an investigation would take at least 18 months and that any resulting disposals could take many years. Miliband said in January that a Labour government would introduce a threshold for personal current accounts and business banking and give the CMA six months to set the limit. Chisolm said the CMA, in shadow form, had been looking at small business banking for about six months.GlaxoSmithKline is planning a multimillion-pound investment in sub-Saharan Africa, the Sunday Telegraph reported. The pharmaceutical giant will announce plans to build up to five new factories on March 31st. It is looking at sites in Ghana, Ethiopia and Rwanda. Glaxo thinks Africa will be one of the fastest growing parts of the world over the next 50 years. Sub-Saharan Africa provides about £500m of Glaxo's £26.5bn annual sales.Land Securities has put on hold plans to build 200 luxury flats near Buckingham Palace until after next year's general election, the Sunday Times reported. The decision is the first sign that threats of a "mansion tax" are affecting developers' plans. The industry fears a 1% tax on homes worth more than £2m - a policy picked up by Labour that housebuilders are concerned the Conservatives will emulate.Royal Bank of Scotland is close to appointing Ewen Stevenson, one of the brains behind the 2008 banking bailout, as its new Finance Director, according to the Sunday Times. Stevenson, co-head of European investment banking at Credit Suisse, is said to have dreamt up the asset protection scheme insurance programme that stopped RBS shareholders being entirely wiped out during the financial crisis.A funding crisis has cast doubt on the future of Britain's second-biggest oil refinery, the Sunday Times said. The Stanlow plant is owned by Essar Energy, the Indian power and mining company whose founders are trying to buy it back after listing in London four years ago. Stanlow has to refinance a £330m loan from Barclays in July after using up £173m of its cash in the nine months to December. Essar said Stanlow was within its debt covenants and that the plant had the advantage of producing lots of diesel and jet fuel, of which the UK produces little.Real incomes in the UK are back to pre-financial crisis levels, the Sunday Times said. Figures in the small print of official figures released on March 28th showed real household disposable incomes were £507.7bn in the second half of last year - up 4% from the first half of 2008. Britain's population has risen in that time but by less than incomes. The figures suggest the squeeze on household budgets is easing fast.Card Factory is planning to join the line of retailers floating on the stock market with a share sale that could value the discount group at more than £700m, the Sunday Telegraph said. Its private equity owner, Charterhouse, is working on a flotation for this summer. Card Factory Chief Executive Richard Hayes told the paper he wanted to expand from 700 stores to as many as 1,100.A Chinese tycoon is in talks to buy House of Fraser for more than £450m, the Sunday Times reported. Yuan Yafei's Sanpower conglomerate has been in talks with House of Fraser for several months. The department store group's Chairman Don McCarthy has accepted the bid and has presented it to the company's other main shareholders for approval. The deal would end plans for House of Fraser to join the procession of retail initial public offerings.
More News
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.